DIANE MCNEIL: Open Payments
NPI 1801334412 · GOOSE CREEK, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,626 in 76 payments from 22 companies in 2025. Trend: 2023 $2,732 · 2024 $2,341 · 2025 $1,626
Food & beverage: $1,626
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $222 |
| Vanda Pharmaceuticals Inc. | 4 | $192 |
| AstraZeneca Pharmaceuticals LP | 6 | $185 |
| Novo Nordisk Inc | 8 | $172 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $147 |
| PFIZER INC. | 6 | $133 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $88 |
| Amgen Inc. | 4 | $84 |
| Astellas Pharma US Inc | 2 | $60 |
| GlaxoSmithKline, LLC. | 2 | $46 |
Products named: FARXIGA, Kerendia, FANAPT, Wegovy, ELIQUIS, UBRELVY, CAPLYTA, QULIPTA.
Industry payments across SC — which companies pay providers there.
